Advertising

TSE:ACB

5.06
0.06 (1.17%) 1d
0
Showing 1 to 15 of 75 entries
HOLD
It's been a wild ride. The valuation across all the names are still quite high. With what we are seeing with legislation in the US, he would still tend to look at these. Stick with it.
0
SELL
Don't buy cannabis stocks here. Their earnings just aren't there. You can buy good value companies at discounts to book value so why go for this one. Move on. It is an opportunity to upgrade your portfolio.
0
DON'T BUY
He saw the bubble coming in cannabis. Take a look at the financial balance sheets and see how much money they owe. He owns one company in the space that also owns liquor stores. You will see more companies go under in this space. He only buys companies that have been around for 10 years.
0
BUY

They each have their own strengths. He would pick Canopy (WEED-T) because they are the 800 lb gorilla. Aurora has lots of news about balance sheet challenges but they have low costs that he thinks will still come down further.

0
DON'T BUY
He feels all cannabis stocks are gambling stocks. A maturing debenture is expected to keep downward pressure on the share price. There is no assurance that any existing company will be a survivor -- it is simply too early. No one is making money in this space. Without being able to predict revenues and expenses, it is too risky. He would stay away from these.
0
DON'T BUY
The cannabis sector has been thrashed and still not good value--no earnings, uncertain sales. Very risky and good luck to you. He doesn't see the fundamentals improving.
0
DON'T BUY
They're reporting soon. There's a lot of oversupply in the sector; the black market sells cheaper weed and legal distribution is tight. This industry is still evolving. There was a lot of froth before in this space. Also, the laws keep changing. Weed companies aren't making money. She's sitting on the sidelines.
0
DON'T BUY
Cannabis? He is fortunate that they have not participated in the cannabis space over the past year. It is just too difficult to determine who will be the winners in this space just yet. A lot of companies will short on cash. ACB has a $200 million debenture coming due in March 2020, which will have to be refinanced as the strike price is well above current prices. Stay away from ACB. He would not buy anything in the space.
0
COMMENT
Short this to $1? $4.50 is its book value and technical support. Has a strong balance sheet, but it has no earnings or fair market value. We're at the stage in cannabis where these stocks have to prove they can survive as a business. Don't short this anymore. The price is so low it's starting to look attractive.
0
DON'T BUY

His weed exposure is through Constellation Brands which owns Canopy--this is less risky than owning cannabis stocks. The valuation on the entire sector rose way too high in 2017-8. Now, the industry is feeling growing pains, with unexpected surprises in working with governments. Generally sin stocks do well long term, but the next year or two will be challenging.

0
DON'T BUY
Cannabis stocks are continuing to go down. They went up on hype and spiked around the time it became legal in Canada. They are having trouble getting their product out and displacing the black market. There is nothing to keep these stocks from going lower. There is tax loss selling coming.
0
HOLD
One of the top four producers of cannabis in Canada. Back to fundamentals, you have to demonstrate the ability to make money. The company has not "super stumbled", but it is not lighting a fire. Trading at 8 times revenue, this space in general requires very high growth rates. It is one of the seniors in the space, so if you like this area it is one to hold.
0
DON'T BUY
The cannabis trade is over and only day traders are in this space. And this will shrink. Cannabis have invested a lot in projects that won't make money. Avoid this sector.
0
COMMENT
Like all cannabis, it's struggling now. The chart is very short, so he has little to analyze. He can't compare this to Canopy; they're too different.
0
DON'T BUY
And the cannabis space in general He doesn't follow cannabis. These companies won't make money for a while as they spend on production capacity and staff. Also, the black market remains as big or bigger than the legal. He's waiting to see how this space shakes out. It's like the dot-com bubble.
0
Showing 1 to 15 of 75 entries

Aurora Cannabis(ACB-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Aurora Cannabis is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Aurora Cannabis(ACB-T) Frequently Asked Questions

What is Aurora Cannabis stock symbol?

Aurora Cannabis is a Canadian stock, trading under the symbol ACB-T on the Toronto Stock Exchange (ACB-CT). It is usually referred to as TSX:ACB or ACB-T

Is Aurora Cannabis a buy or a sell?

In the last year, 1 stock analyst published opinions about ACB-T. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Aurora Cannabis.

Is Aurora Cannabis a good investment or a top pick?

Aurora Cannabis was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Aurora Cannabis.

Why is Aurora Cannabis stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Aurora Cannabis worth watching?

1 stock analyst on Stockchase covered Aurora Cannabis In the last year. It is a trending stock that is worth watching.

What is Aurora Cannabis stock price?

On 2022-01-27, Aurora Cannabis (ACB-T) stock closed at a price of $5.06.